Dalagon, Deborah N.

HRN: 13-28-20  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2024
CEFTAZIDIME 1GM (VIAL)
02/20/2024
02/26/2024
IV
1 Gram
Q 12 Hrs
Sepsis
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: